LEVOCETRIZINE AND DESLORATADINE: COMPARATIVE EFFICACY IN PATIENTS WITH ALLERGIC RHINITIS

被引:0
|
作者
Khan, Shimal [1 ]
Khan, Muhammad Ismail
Khan, Asmatullah
Abrar, Amjad
机构
[1] Gomal Med Coll, Dept Pharmacol, Dera Ismail Khan, Pakistan
来源
GOMAL JOURNAL OF MEDICAL SCIENCES | 2012年 / 10卷 / 01期
关键词
Allergic rhinitis; Levocetrizine; Desloratadine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Antihistamines are the most commonly prescribed class of medication for allergic rhinitis. The objective of this study was to compare efficacy of levocetrizine and desloratadine in once daily dosage in patients suffering from allergic rhinitis. Methods: This study was carried out from 1st January 2011 to 31st December 2011, in Department of ENT and Pharmacology, Gomal Medical College D. I. Khan. Patients of > 12 years age with symptomatic allergic rhinitis attending ENT OPD were included. They were divided in two groups. Group A was given levocetrizine 5 mg once daily and Group B desloratadine 5 mg once daily. Data was collected at first visit prior to medication, second visit 2 weeks and third at 4 weeks. Total-4 nasal symptoms score (rhinorrhoea, sneezing, nasal itching, and nasal obstruction) were compared. Results: A Total 140 patients were included; 42 males and 28 females in group A while 52 males and 18 females in group B. Mean age in group A was 27.4 +/- 9.3 while in group B 27.5 +/- 8.9 years. Total-4 nasal symptoms score was 13-14 in 76% patients at visit 1 in levocetrizine group that improved to 6-7 in 25% and 4-5 in 70% patients at visit 2 and 3 respectively. Patients receiving desloratadine had 13-14 in 58% at visit 1 with an improvement to 4-5 in 21% and 65% at visits 2 and 3 respectively. Conclusion: There is no difference between levocetrizine and desloratadine in relieving individual symptom score in symptomatic allergic rhinitis.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 50 条
  • [21] The safety and efficacy of desloratadine for the treatment of perennial allergic rhinitis: A multicenter study in Poland
    Ciebiada, M.
    Gorska-Ciebiada, M.
    Gorski, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A91 - A91
  • [22] Efficacy of Desloratadine in Persistent Allergic Rhinitis - A GA2LEN Study
    Bousquet, Jean
    Bachert, Claus
    Canonica, Giorgio W.
    Mullol, Joaquim
    Van Cauwenberge, Paul
    Jensen, Carsten Bindslev
    Fokkens, Wystke J.
    Ring, Johannes
    Keith, Paul
    Gopalan, Gokul
    Lorber, Richard
    Zuberbier, Torsten
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2010, 153 (04) : 395 - 402
  • [23] Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis
    Lee, DKC
    Gardiner, M
    Haggart, K
    Fujihara, S
    Lipworth, BJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (04): : 650 - 653
  • [24] Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis
    Berger, William E.
    Lumry, William R.
    Meltzer, Eli O.
    Pearlman, David S.
    ALLERGY AND ASTHMA PROCEEDINGS, 2006, 27 (03) : 214 - 223
  • [25] A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis
    Passalacqua, G
    Canonica, GW
    CLINICAL THERAPEUTICS, 2005, 27 (07) : 979 - 992
  • [26] Effectiveness of desloratadine in improving quality of life in patients with persistent allergic rhinitis
    Kaulsay, R.
    Rampa, S.
    Puraviappan, P.
    ALLERGY, 2007, 62 : 490 - 491
  • [27] The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis
    Sullivan, Patrick W.
    Navaratnam, Prakash
    Lorber, Richard
    Shekar, Tulin
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (06) : 1389 - 1397
  • [28] Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis
    Pradalier, A.
    Neukirch, C.
    Dreyfus, I.
    Devillier, P.
    ALLERGY, 2007, 62 (11) : 1331 - 1334
  • [29] Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients
    Bachert, C.
    Kuna, P.
    Sanquer, F.
    Ivan, P.
    Dimitrov, V.
    Gorina, M. M.
    van de Heyning, P.
    Loureiro, A.
    ALLERGY, 2009, 64 (01) : 158 - 165
  • [30] Efficacy and Safety of Desloratadine/Pseudoephedrine Combination vs Its Components in Seasonal Allergic Rhinitis
    Grubbe, R. E.
    Lumry, W. R.
    Anolik, R.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2009, 19 (02) : 117 - 124